Guangdong-based No.1 Pharmacy Chain, operator of online medicine retail platform 111.com.cn, has announced a strategic partnership with Beijing-based pharmaceutical company Scrianen Pharmaceutical to provide pre-pregnancy and pregnancy healthcare solutions.
Scrianen currently operates an official store on the 111.com.cn platform, and in the future, 111.com.cn will provide Scrianen with a full range of pharmaceutical supply chain services, including warehouse management, product delivery, and after-sales service.
The two sides will explore collaborations that include integrating user data, allying on marketing, and sharing specialist resources. They will also explore content marketing, such as providing users with various pre-pregnancy and pregnancy expert guidance and education in the form of short videos and live streams.
Scrianen board chairman Yi Bin said that the company will supply 111.com.cn with guaranteed genuine drug and pregnancy products direct from the manufacturer, and will work together with 111.com.cn to help more users learn about Scrianen and its products.
In April 2016, 111.com.cn launched a "genuine goods alliance," and to date has formed strategic partnerships with dozens of companies to explore and collaborate in areas such as big health management, online marketing, and big data applications.
Editor's Note: While China last year halted trial licenses to operate third-party drug retail platforms, 111.com.cn still allows third-party drug sellers to establish official stores on its platform. These official stores do not actually sell drugs, but require the user to go to an offline store to buy the drugs. For more information on 111.com.cn's Series D funding, as well as the Chinese Food and Drug Administration's decision to halt trial licenses to operate third-party drug retail platforms, please see "Medicine E-tailer 111.com.cn Wins RMB 10-digit Series D," MD 10/16/15 and "CFDA Officially Halts Trial Licenses to Operate Third-party Drug Retail Platforms," MD 7/28/16.